Upload
john-theurer-cancer-center-at-hackensack-university-medical-center
View
47.375
Download
9
Tags:
Embed Size (px)
DESCRIPTION
An overview of the John Theurer Cancer Center at Hackensack University Medical Center - a top-50 U.S. News & World Report Best Hospitals for Cancer – the only cancer center in New Jersey with this prestigious designation. To request printed copies of this brochure, please contact [email protected].
Citation preview
Providing Extraordinary Care
John Theurer Cancer Center
One of the Nation’s Top 50 Cancer Centers
For the past 25 years, John Theurer Cancer Center
at Hackensack University Medical Center has
become one of the largest and most comprehensive
cancer centers in the United States. Today, we are
a top-50 U.S. News & World Report Best Hospitals
for Cancer – the only cancer center in New Jersey
with this prestigious designation.
jtcancercenter.org201-996-5900
A Message from Dr. Pecora and Dr. Goy AttheJohnTheurerCancerCenter,webelievecancerishardenoughforpatientsandtheirlovedones.Itisthisbeliefthatdrivesourpassiontodeliverextraordinarycareeveryday,helpingusbecomeoneofthenation’stop50cancercenters–theonlycancercenterinNewJerseywiththisrecognition.
Overthepast25years,wehavebecomeoneofthelargestcancercentersintheUnitedStates,butwehavekeptourfocusontheuniqueneedsofthepatientswhoplacetheirtrustinourdoctorsandstaff.Prevention,treatment,andresearchadvanceshavegrownexponentiallyoverthose25years.Wearenotonlykeepingupwiththechangeofpace,weareattheforefrontofdeliveringinnovativecare,andprovidingtomorrow’streatmenttodayby:
• Taking multidisciplinary care to a new levelwithteamsofdisease-specificexpertsunderoneroof• Delivering personalized medicinefocusedonnoveltherapies,participatorytreatment,predictive
measures,andpreventivecare• Advancing researchthroughbiomarker-drivenclinicaltrialsandtranslationalresearch• Providing holistic carethatincludesawiderangeofcomplementaryservicesimportanttothe
well-beingofourpatientsthatcanbeeasilyintegratedintotheircare• Creating a comforting environmentinanewhigh-tech,high-touchbuilding
Webelieveourmodelisthenextsteptowardthefutureofpatientcare.Inthepagesthatfollow,weinviteyoutoseehowtheJohnTheurerCancerCenterischangingthecancercareexperienceonepatientatatime.
Sincerely,
Andrew Pecora,M.D.,F.A.C.P.,C.P.E.ChiefInnovationsOfficer,ProfessorandVicePresidentofCancerServices,JohnTheurerCancerCenteratHackensackUniversityMedicalCenter
Andre Goy,M.D.,M.S.ChairmanandDirector,ChiefofLymphoma,andDirector,ClinicalandTranslationalCancerResearch,JohnTheurerCancerCenteratHackensackUniversityMedicalCenter
message
Innovative Care in a Patient-Centered EnvironmentThelobbyfeaturesaflightof200soaringMuranoglassblownbirdsandaninspiringLivingWallmadeofover30plantspecies,allhydroponicallygrowingwithoutsoilandaccompaniedbya24-footwaterfall.Thewallbreaksdownindooraircontaminatesthroughentirelynaturalprocesses,releasingpurer,cleanerair.
Otherresourcestohelppatientsandcaregiversintheirfightagainstcancerinclude:
• Tranquility/meditationroom,fitnessstudio,andyogaclassesthatarefreeforpatients
• Terracegardenwithavegetablegardentoteachcancerpatientshowtogrowtheirownfood
• Patientresourcelibrarywithamedicallibrarianandcybercafétostayconnected
• Demonstrationkitchenforcookingandnutritionlessons
jtcancercenter.org
A New Building to Deliver Extraordinary CareInJanuary2011,weopenedanewbuildingthatnowhousesour14specialtydivisionsalongwithourresearchandoncologyservices.Thisprovidesourpatientswithanunparalleledexperiencethroughinnovativeapproachesincomfortablesurroundings.
facilities
John Theurer Cancer Center Practice SpecialtiesWe are comprised of 14 specialized divisions and Radiation Oncology experts. Division Chiefs are supported by medical, research, nursing, nutrition, and psychosocial support for more advanced, focused care for patients.
Blood and Marrow Stem Cell Transplantation Program
Lymphoma Division
Multiple Myeloma Division
Leukemia Division
Neuro-Oncology Division: Brain and Spine Institute
Skin and Sarcoma Division: Cutaneous Malignancy Program
Gastrointestinal Oncology Division
Geriatric Oncology Division
Head and Neck Oncology Division
Thoracic Oncology Division
Radiation Oncology Department
Urologic Oncology Division
Breast Oncology Division
Gynecologic Oncology Division
Research Division
specialtiesspecialtiesspecialtiesspecialtiesspecialties
• ParticipatesingroundbreakingresearchfundedbytheSusanVaughanFoundationforTranslationalResearchinLymphoma,theFDA,andseveralpharmaceuticalcompanies.
• Dr.Goyiswidelyknownforhisworkasco-principalinvestigatoronthePINNACLEtrial,whichledtotheFDA’sapprovalofVELCADE®(bortezomib)foradefinedgroupofmantlecelllymphomapatients.
• Dr.GoytookpartintheoriginalpilotstudyforRITUXAN®(rituximab),whichdoctorshavewidelyusedtotreatlymphomas,leukemias,andautoimmunedisorders.
• Dr.GoyisamemberoftheLymphomaResearchFoundation’sScientificAdvisoryBoard,whichiscomprisedoftheworld’sleadinglymphomaresearchersandoncologists.
• CollaborateswiththeLymphomaResearchFoundationtopresentthelatestpracticesinthediagnosisandmanagementoflymphoma.
Lymphoma Andre Goy,M.D.,M.S.,ChairmanandDirector,Chief,LymphomaandDirector,ClinicalandTranslationalCancerResearch
Tatyana Feldman,M.D.,Attending,Lymphoma
Anthony Mato,M.D.,Attending,Lymphoma
Pritish Bhattacharyya,M.D.,Pathology,Lymphoma
Kar Chow,M.D.,Pathology,Lymphoma
Xiao Yang,M.D.,Ph.D.,Pathology,Lymphoma
Anthony Ingenito,M.D.,Chairman,RadiationOncology
LedbyinternationallyrenownedclinicianandresearcherDr.Goy,theLymphomaDivisionisdedicatedtotreatingcancersofthelymphaticsystem,includingHodgkinlymphomaandnon-Hodgkinlymphomaandseriousblooddisorderssuchasamyloidosis.
Hematological Malignancies Our clinicians are leading some of the most significant research for blood-borne cancers today. In 2010, we presented research updates and clinical trial results of 40 cutting-edge studies at the annual American Society of Hematology Meeting, including multicenter, international trials in collaboration with leading cancer institutions, such as the National Cancer Institute (NCI), MD Anderson, Dana-Farber, Mayo Clinic, and Memorial Sloan-Kettering.
• Morethan30clinicaltrialsunderway,includingmulticenterstudiesincollaborationwiththeNCIandNationalMarrowDonorProgram.
• PartoftheBoneMarrowTransplantClinicalTrialsNetworkandEasternCooperativeOncologyGroup,allowingustocollaborateonnationalclinicaltrials.
• Clinicaltrialscovermultipleareas:leukemia(AML,ALL,CLL,CML),plasmacelldyscrasias(myeloma,amyloidosis,Waldenstrom’s),
lymphoma(non-Hodgkin,Hodgkin)aswellasmyelodysplasticandmyeloproliferativedisordersandhemoglobinopathies(sicklecellanemia).
• Extensiveexperienceinstemcelltransplanttherapyformultiplemyeloma.
• Performsmorephotopheresisproceduresthananytransplantationprograminthecountry.
Blood and Marrow Stem Cell Transplantation Scott Rowley,M.D.,F.A.C.P.,Chief,BloodandMarrowStemCellTransplantationProgram
Michele Donato,M.D.,MedicalDirector,BloodandMarrowCollectionFacility
David Vesole,M.D.,Ph.D.,Co-ChiefandDirector,Research,MultipleMyeloma
Andrew Pecora,M.D.,F.A.C.P.,C.P.E.,ChiefInnovationsOfficer,ProfessorandVicePresidentofCancerServices
Oneofthenation’s10largestadultBloodandMarrowStemCellTransplantprograms,performingmorethan300transplantslastyearandmorethan4,000total.
• ActiveinclinicaltrialsthatledtoFDAapprovalofGLEEVEC®(imatinibmesylate)andanewindicationforTasigna®(nilotinib).
• Dr.Goldbergisinternationallyrecognizedforhisresearchinleukemiaandotherbloodcancers.InApril2010,heledresearchpublishedintheJournalofClinicalOncology,whichconcludedmyelodysplasticsyndromesbloodcancerisfivetimesmorecommonthanpreviouslythought.
• Partnerswithmultiplepatientsupportsgroups,suchastheLeukemia&LymphomaSociety,tohosteducationaleventsandtoprovideimportantprogramsforpatientsandtheirlovedonesaswellasforhealthcareprofessionals.
Leukemia Stuart Goldberg,M.D.,Chief,Leukemia
Pritish Bhattacharyya,M.D.,Pathology,Leukemia
Kar Chow M.D.,Pathology,Leukemia
Anthony Ingenito,M.D.,Chairman,RadiationOncology
TheLeukemiaDivisionusesavarietyoftreatmentoptions,includingchemotherapyandstemcelltransplantation,toensurepatientsreceivethebestcareavailable.
“When I was diagnosed with multiple myeloma, they told me I had up to
three years to live. Thanks to access to the latest clinical trials and great
personnel, I have spent the last 17 years traveling the world and
watching my grandchildren become adults.”
—George Chambers, 17-year multiple myeloma survivor
• MemberoftheMultipleMyelomaResearchConsortium(MMRC),auniqueresearchmodelconsistingof16institutionstoacceleratethedevelopmentofnovel,cutting-edgemultiplemyelomatreatments.
• Dr.SiegelandDr.Vesolearetwooftheforemostinternationalauthoritiesinmultiplemyeloma,frequentlypublishedintop-tierpeer-reviewedmedicaljournalssuchasJournalofClinicalOncology,Blood,LancetOncology,andTheNewEnglandJournalofMedicine.
• Participatedinlandmarkresearchthathasledtotheapprovalofsomeofthemostsignificantmultiplemyelomatherapiesused
today,includingVELCADE®(bortezomib),REVLIMID®(lenalidomide),Pomalidomide,andCarfilzomib.
• Ourresearchersjoinedcolleaguesfrom20institutionstopublishthefirstcompletegenomicportraitofmultiplemyeloma.
• Aleaderininnovativestemcelltransplantmodalitiesforthetreatmentofmultiplemyeloma.
Multiple Myeloma David Siegel,M.D.,Ph.D.,Chief,MultipleMyeloma
David Vesole,M.D.,Ph.D.,Co-ChiefandDirector,Research,MultipleMyeloma
Joshua Richter,M.D.,Attending,MultipleMyeloma
OneofthefewfacilitiesintheU.S.toprovidespecializedexpertiseinmultiplemyeloma,primarysystemicamyloidosisandWaldenstrom’smacroglobulinemia,offeringnewandemergingtherapiesthatenhancethequalityandextendthelifeofpatientswithplasmacelldisorders.
Multiple MyelomaResearch Consortium
Powerful Collaboration Accelerates Results
“I would have gone anywhere to get the best possible treatment, but I found
it right here in Hackensack. My friends and family didn’t have to travel into
New York City during my lengthy hospital stay and the care I received was first-rate.”
—Julie Mott, leukemia survivor and 8th person in the world to survivealivertransplantandstemcelltransplant
• OneofthelargestsurgicalmelanomapracticesinNewJersey,conductingmorelymphaticcasesthananyotherinthestate.
• OneoftheonlycancercentersinNewJerseywithadermatopathologistonthestaff.
• ExtensiveexpertiseinMohsmicrographicsurgery,aspecializedprocedurethathasthehighestcurerateofallsurgicaltreatmentsforbasalcellandsquamouscellcarcinoma.
• InvolvedinthelandmarkstudythatledtotheFDA’sfasttrackandapprovalofYERVOY™(ipilimumab),abreakthroughtreatmentformetastaticmelanoma.
• Extensiveexperienceinlimb-sparingsurgeryforshouldergirdletumors,cryosurgery,radiofrequencyablation,andminimallyinvasivebiopsies.
Skin and Sarcoma: Cutaneous Malignancy Program Andrew Pecora,M.D.,F.A.C.P.,C.P.E.,ChiefInnovationsOfficer,ProfessorandVicePresidentofCancerServices,andChief,CutaneousMalignancyProgram
Donald McCain,M.D.,Ph.D.,ViceChairmanandChief,SurgicalOncology,CutaneousMalignancyProgram
James Wittig,M.D.,Chief,SarcomaCancerandChief,OrthopedicOncology
Robin Ashinoff,M.D.,Chief,Dermatologic,MohsandLaserSurgery
Richard Winters,M.D.,F.A.C.S,Vice-Chairman,PlasticandReconstructiveSurgery
Anthony Ingenito,M.D.,Chairman,RadiationOncology
ProvidesamultidisciplinaryteamofleadingexpertsinMohssurgery,dermatopathology,dermatology,medicaloncology,oncologicsurgery,radiationoncology,reconstructivesurgeryandresearch.Ourprogramtreatsallstagesofmalignantmelanoma,squamouscellcarcinoma,basalcellcarcinoma,andothercutaneousmalignancies.
“I was diagnosed with a brain tumor when I was four months pregnant.
It wasn’t certain that the entire tumor could be removed, but Dr. Kaptain took on
my case and I’ve been in remission for five years. It is nothing short of a miracle.”
—AntoniaReyes,braincancersurvivor
• Ledbyneuro-oncologistDr.Goldlust,whorecentlyjoinedfromMemorialSloan-KetteringCancerCenterandneurosurgeonDr.Kaptain,whohassubspecialtytrainingbothinneuro-oncologyandskull-basesurgery.
• Multidisciplinaryteamincludesexpertsinneurology,neurosurgery,medicaloncology,radiationoncology,behavioralhealth,neuroradiology,otolaryngology,pathology,andnursing.
• Researchisfocusedupondevelopingnoveltherapeuticsforprimaryandmetastaticbraintumors,improvingcarefortumor-relatedepilepsy,anddevelopingstrategiesforneuro-protectionincancerpatients.
• Oneofonly20facilitiesintheU.S.toofferMRI-guidedlaserinterstitialthermaltherapy,anoveltechnologythatallowsforprecisionremovaloftumorsthatmayotherwisebeinoperable.
• Advancedimagingcapabilitiesincludediffusiontensorimaging,anMRItechniquethatallowsprecisionmappingofneuralpathwaysinthebrain.Withthisandotherrelatedimagingmodalities,ourphysiciansareabletominimizeharmtonormaltissuesduringtreatment.
• TheAnnualNeuro-OncologySymposiumbringstogetherworldrenownedexpertstodiscussrecentbreakthroughsandtrendsinthefield.
Neuro-Oncology: The Brain and Spine Institute Samuel A. Goldlust,M.D.,Co-Chief,TheBrainandSpineInstitute
George Kaptain,M.D.,Co-Chief,TheBrainandSpineInstitute
Hooman Azmi,M.D.,Neurosurgeon,TheBrainandSpineInstitute
Mark Pascal,M.D.,Neuro-oncologist,TheBrainandSpineInstitute
David Panush,M.D.,SectionHead,Neuroradiology,DiagnosticRadiology
Anthony Ingenito,M.D.,Chairman,RadiationOncology
In2011,theJohnTheurerCancerlaunchedtheBrainandSpineInstitutetocoordinatemulti-disciplinarycuttingedgecareandresearchforprimaryandmetastaticbraintumorsaswellastheneurologicalcomplicationsofcancer.
• Bringstogetherexpertsinotolaryngology(ear,nose,andthroatmedicine),plasticandreconstructivesurgery,medicaloncology,maxillofacialsurgery,dentistry,radiationoncology,radiology,andnursing.
• HostsannualHeadandNeckCancerForumthatprovidessupport,networking,andinformation.
• Activeresearchinradiationapproachestoimproveoutcomesandqualityoflifeforheadandneckcancerpatients.
Head and Neck Oncology Loren Godfrey, M.D., Co-Chief, Head and Neck Oncology and Director, BrachytherapyBrian Benson, M.D., Co-Chief, Head and Neck Oncology
Our specialized team is dedicated to preventing, diagnosing, treating, and managing cancers of the head andneck,includingcancersofthemouth,throat,tongue,thyroid,andsinuses.
• OneofthemostactivethoraciconcologyclinicaltrialsitesinNewJersey.
• Internationallyrecognizedleadersinminimallyinvasivesurgicalapproachestothoraciccancertreatment.
• Dr.Parkisoneoftheoriginalinnovatorsinroboticvideo-assistedthoracicsurgery(VATS)
lobectomy,aminimallyinvasiveprocedurethatcandecreaserecoverytime,usingthedaVinci™surgicalsystem.
• Employingadvanceddiagnostictechniquessuchasendobronchialultrasound(EBUS)andnavigationalbronchoscopy.
Thoracic Oncology Bernard Park,M.D.,Co-Chief,ThoracicOncologyHarry Harper,M.D.,Co-Chief,ThoracicOncologyAnthony Ingenito,M.D.,Chairman,RadiationOncology
OneofonlyahandfulofcancercentersinNewJerseywithafull-timemultidisciplinarythoraciconcologyteam,specializinginthediagnosisandtreatmentoflungcancer,esophagealcancer,malignantmesothelioma,mediastinaltumors,andothercancerswithinthechest.
• ExtensiveexpertisewiththedaVinci®roboticsurgerysystemforminimallyinvasive,precisesurgeries.
• Endoscopicultrasoundforearlydetectionofgastrointestinaldiseases.
• Expertsinlaparoscopicliverresections,asurgicaltechniquethatallowspatientstogo
homeearlierandrecoverfastercomparedtoopenprocedures.
• Openandroboticcolonresections,whereapartortheentirecolonisremoved.
• Extensiveexperiencetreatingprimaryandmetastaticlivertumorswithhepaticresectionsandradiofrequencyablation.
Gastrointestinal Oncology Andrew Jennis,M.D.,Co-Chief,GastrointestinalOncology
Donald McCain,M.D.,Ph.D.,F.A.C.S.,ViceChairmanandCo-Chief,GastrointestinalOncology
Anthony Ingenito,M.D.,Chairman,RadiationOncology
Ourteamofmorethan20expertsingastroenterology,surgery,medicaloncology,radiationoncology,radiology,pathologyandnursingisdedicatedtocancersofthegastrointestinalsystem.Ourteamoffersinnovativetreatmentsandsurgicalapproachestoimproveoutcomesanddecreaserecoverytime.
• Afocusontheuniqueneeds,treatment,andrecoveryofpatientsage65andolder.
• Operatesanactivepain-managementprogramandextensivepalliativecareservicesthataddressend-of-lifeissuesandattempttoeasepainanddiscomfortforpatients.
Geriatric Oncology Richard Rosenbluth,M.D.,Chief,GeriatricOncology
ThisisthefirstdedicatedprogramdesignedforseniorcancerpatientsinNewYorkandNewJersey.
• Usesthemostadvanceddiagnosticandtreatmentmethodsavailable,includingminimallyinvasive,laparoscopic,TomoTherapy®,roboticsurgicalprocedures,andcryosurgery.
• FirstcancercenterinNewJerseytoofferthecompletecapabilitiesofbreakthroughimmunotherapyProvenge®(sipuleucel-T)treatment.Prostatecancerpatientscanreceiveacell-collectionprocessandinfusionbyasingleteam,allowingforamoreintimate,comfortingcourseoftreatment.
• Thelargest high-dose-rate(HDR)brachytherapycenterinthetri-statearea, whichallowsphysicianstodeliverpreciseradiationtreatmentdirectlytoatumors.
• MostexperiencedTomoTherapy® radiation centerinNewJerseyforprostatecancer,whichis oneofthemosteffective radiation methodsfortargetedprostatecancertreatment.
• Roboticsurgerytrainingsiteforthenortheast.
• RankednumberoneinNewJerseybyHealthgradesforprostatectomy.
• Activeinclincialtrialsforprostate,renalandbladdercancer.
Urologic Oncology Ihor Sawczuk,M.D.,Co-Chief,UrologicOncologyandChairman,DepartmentofUrology
Robert Alter,M.D.,Co-Chief,UrologicOncology
Glen Gejerman,M.D.,Co-Chief,UrologicOncologyandDirector,RadiationOncology
Thismultidisciplinaryteam,whichincludessomeofworld’sleadersinurologiconcology,isdedicatedtocancersofthegenitourinarysystem,includingkidneys,adrenalglands,ureters,bladder,prostategland,testes,andmalegenitalia.
“The yoga classes have helped improve my breathing, relaxation, and flexibility.
More importantly, it shows me that the doctors and staff don’t just want to
treat my cancer – they truly care about my total well-being.”
—Bimla Shukla, breast cancer patient
• Amultidisciplinaryteamincludingboard-certifiedradiationoncologists,medicalphysicists,technologists,radiationtherapists,medicaldosimetrists,certifiedmedicalassistants,socialworkers,andregistereddietitians.
• AccreditedbytheAmericanCollegeofRadiationOncology.
• Safetyprogramrankedabovethe95thpercentilebytheAmericanCollegeofRadiology,andpatientsatisfactionscoresarealsorankedinthe95thpercentileorgreatercomparedtopeers.
• FirstcancercenterinNewJerseytoacquireTrueBeam™,whichenablesaradicallydifferentapproachtotreatingcancerwithimage-guided
therapy,andtheonlycancercenterinthecountrytoacquiretwomachines.
• MostexperiencedcancercentertoofferTomoTherapy®,treatingprostate,lung,andheadandneckcancerwithunparalleledaccuracy,precision,andsafety.
• Activeinclinicaltrials,withresearchinnewapproachessuchasbrachytherapy,DoseVerificationSystem®(DVS),andTomoTherapy®.
• Implantsabreakthroughradiationmeasurementtechnology,knownasDVS®,whichprovidesdataontheamountofradiationdeliveredtotumorsandsurroundingtissue.
• Above-groundradiationfacility.
Radiation Oncology Anthony Ingenito,M.D.,Chairman,RadiationOncology
Glen Gejerman,M.D.,Co-Chief,UrologicOncologyandDirector,RadiationOncology
Loren Godfrey,M.D.,Co-Chief,HeadandNeckandDirector,Brachytherapy
Providesthemostadvancedradiationtherapytreatmentmethodsandadedicatedteamofon-siteradiationoncologistswithdisease-specificexpertise.
• Accesstomultipleclinicaltrialsinovarian,uterine,andcervicalcancers,includingnationaltrialsledbytheGynecologicOncologyGroup,acooperativecancerresearchgroupfundedbytheNCI.
• Oneofonly20centersinthecountryselectedtotrainphysiciansfortherevolutionarydaVinci®surgicalrobot,whichmakesgynecologiccancersurgeryeasierandsafer.
• Expertsinminimallyinvasivesurgicaloptions,includinglaparoscopicandroboticsurgery.
• Oneoffewcentersskilledinbothintracavitaryandinterstitialhigh-dose-rategynecologicbrachytherapytechniques–advancedcancertreatmentsthatdeliverpreciseradiationdirectlyintotumors,typicallyonanoutpatientbasis.
Gynecologic Oncology Donna McNamara,M.D.,Co-Chief,GynecologicOncology
Babak Litkouhi,M.D.,Co-Chief,SurgicalGynecologicOncology
Ami Vaidya,M.D.,Director,GynecologicRoboticSurgery
Loren Godfrey,M.D.,RadiatonOncologist,GynecologicOncology
TheGynecologicOncologyDivisionprovidesourfemalepatientswithextraordinarycarefromleadingphysicianswhounderstandtheuniquechallengesofwomenbattlingcancer.
TheMaureenFundisacommunity-educationoutreachprogramthatprovidesovariancancerscreeningsandpreventionservicesforwomen.
• Accesstomultipleclinicaltrialsin breastcancer,includingnationaltrialsledbytheCancerandLeukemiaGroupBandEasternCooperativeOncologyGroup,aswellasaccesstonewPhaseIdrugs.
• OneofthelargestclinicaltrialsitesforHerceptin®(trastuzumab),adrugthatchangedthelandscapeforbreastcancercare.
• OfferspartialbreastirradiationusingMammoSite®targetedradiationtherapy,whichreducestreatmentfromsixweekstofivedaysformanypatients.
• Eachyear,weinviteleadingbreastoncologiststopresentthelatestresearchfindingstophysiciansandhealthcareprofessionalssotheycanapplytheselearningstotheclinic.
Breast Oncology Stanley Waintraub,M.D.,Co-Chief,BreastOncology
Mary Jane Warden,M.D.,ActingCo-Chief,BreastOncology
Loren Godfrey,M.D.,RadiatonOncologist,BreastOncology
OurBreastOncologyDivisionisoneofonlyahandfuloffacilitiesinNewJerseytoofferthemostinnovativetreatmentoptionsdeliveredbyanintegrated,prominentlytrainedgroupofhighlyspecializedbreastcancerexperts.
Women’s Health Oncology Services We offer a depth of expertise that has propelled our women’s health center to a leadership role in the national fight against cancers specific to women.
TheAngelsofHopeFoundationhascreatedacomfortingenvironmentontheWomen’sHealthfloor,withabeautifulwaitingareatohelppatientsfeelateasepriortotheirappointments.Theirgenerousdonationsalsoprovideservicesforwomenwithcancerwhootherwisecouldnotaffordthem.
www.aoh-nj.org
Extraordinary Care Means Cutting-Edge Research Andre Goy, M.D., M.S., Chairman and Director, Chief, Lymphoma and Director, Clinical and Translational Cancer Research
Robert Korngold, Ph.D., Chairman, Research
Martin Gutierrez, M.D., Director, Drug Discovery/Phase 1 Unit
We have been conducting bench to bedside research for more than two decades. Today, a large part of our research is supporting personalized medicine and targeted therapies that we believe can help researchers and clinicians improve outcomes. We have established relationships with cooperative research groups and the pharmaceutical and biotech industry to help bring innovative and translational drugs from Phase I and Phase II trials into the clinic for the benefi t of our cancer patients and patients around the globe.
• More than 200 open, actively enrolling clinical trials and a strong translational research program.
• Leading multicenter, international trials in collaboration with other cancer institutions, such as the NCI, MD Anderson, Dana-Farber, Mayo Clinic, and Memorial Sloan-Kettering.
• More than 120 peer reviewed publications published in the last four years to advance cancer research.
• Part of the Bone Marrow Clinical Trials Network, Eastern Cooperative Oncology Group, and Multiple Myeloma Research Consortium allowing us to collaborate on national clinical trials.
• One of few sites in New Jersey to offer molecular staging and classifi cation capabilities.
• Phase I Clinical Oncology program with an outpatient clinic and a dedicated inpatient bed facility.
• The Tumor Bank has collected more than 2,000 high-quality specimens to advance cancer research.
• Participates in a unique partnership with the National Cancer Institute to establish a joint clinical research program to develop innovative immunology-based translational research approaches around bone marrow transplantation.
• Immunology laboratory leads cutting-edge stem cell research focused on improving allogeneic bone marrow transplant by mitigating the effects of Graft vs. Host Disease.
• Clinical trial site for many breakthrough therapies, such as VELCADE® (bortezomib), GLEEVEC® (imatinib mesylate), Tasigna® (nilotinib), Provenge® (sipuleucel-T), Herceptin® (trastuzumab), Avastin® (bevacizumab), YERVOY™ (ipilimumab).
research
Search For Clinical Trials
jtcancercenter.org/[email protected]
John Theurer Cancer Center at Hackensack University Medical Center
92 Second Street, Hackensack, NJ 07601 • 201-996-5900
jtcancercenter.org
Celebrating Life and Liberty Everyyear,wecelebratewithallofourpatientsandtheirlovedonesatLibertyStatePark.ThisSeptember,morethan2,200peoplejoinedusandwehopethiscelebrationcontinuestogrow.
“The John Theurer Cancer Center gave me personal attention and made me a part of the treatment team
– they didn’t just treat me as another statistic.”
—SusanWinton,pancreaticcystadenomasurvivor
jtcancercenter.org 201-996-5900Join JTCancerCenter Online
©2011